Background Acute myeloid leukemia (AML) patients with a Fms‐like tyrosine kinase 3 (FLT3)
mutation have a high incidence of relapse despite allogeneic hematopoietic stem cell …

Whether a graft-versus-graft (GVG) response in patients undergoing allogeneic hematopoietic
stem cell transplantation (HSCT) is associated with an enhanced graft-versus-leukemia (…

To explore the efficacy, and safety of the intensive conditioning regimen consisting of
cladribine, cytarabine (Ara-C), and granulocyte colony-stimulating factor (G-CSF) plus modified …

Background The development of the targeted signal transduction inhibitor STI571 has
prompted us to treat chronic myeloid leukemia in different ways. Since STI571 may reverse …

Objective To study the type and corresponding clinical characteristics of primary hemophagocytic
lymphohistiocytosis (HLH) associated immune gene mutations in the refractory virus …

Refractory or relapsed acute myeloid leukemia (R/R AML) remains the major challenge of
AML treatment. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only …

Pre‐eclampsia is a leading cause of maternal and foetal morbidity and mortality worldwide.
Insufficient uteroplacental oxygenation is believed to be responsible for the disease. …

This study was purposed to analyze the characteristics of morphology, immunology,
cytogenetic and molecular biology of leukemia cells in 12 AML patients with Ph (+) and their …

Background: Invasive fungal diseases (IFDs), such as invasive mucormycosis (IM) and
invasive aspergillosis (IA), are life-threatening infections that remain a major cause of morbidity …

To explore the possibility of leukemia cell line of both bcr-abl and mdr-1 positive were cross-resistant
to tyrosine kinase inhibitor STI571 and its reversal way, the inhibitory effect of …